Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Bloemendal HJ"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-12 z 12
    Tytuł:
    The predictive value of cumulative toxicity for quality of life in patients with metastatic colorectal cancer during first-line palliative chemotherapy
    Autorzy:
    Schuurhuizen CSEW
    Verheul HMW
    Braamse AMJ
    Buffart LM
    Bloemendal HJ
    Dekker J
    Konings IRHM
    Pokaż więcej
    Temat:
    Cumulative toxicity
    treatment-related toxicity
    adverse events
    quality of life
    metastatic colorectal cancer
    Neoplasms. Tumors. Oncology. Including cancer and carcinogens
    RC254-282
    Źródło:
    Cancer Management and Research, Vol Volume 10, Pp 3015-3021 (2018)
    Opis pliku:
    electronic resource
    Relacje:
    https://www.dovepress.com/the-predictive-value-of-cumulative-toxicity-for-quality-of-life-in-pat-peer-reviewed-article-CMAR; https://doaj.org/toc/1179-1322
    Dostęp URL:
    https://doaj.org/article/236c04f7327742628294fe7b41eaf425  Link otwiera się w nowym oknie
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for 'Trial within Cohorts' study designs.
    Autorzy:
    Yildirim H; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands. .; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC location University of Amsterdam, 4F De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands. .
    Widdershoven CV; Department of Urology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.
    Aarts MJ; Department of Medical Oncology, GROW-School for Oncology and Development Biology, Maastricht University Medical Centre+, Maastricht, the Netherlands.
    Bex A; Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; The Royal Free London NHS Foundation Trust, London, UK.; UCL Division of Surgery and Interventional Science, London, UK.
    Bloemendal HJ; Department of Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
    Bochove-Overgaauw DM; Department of Urology, Gelre Hospitals, Apeldoorn/Zutphen, The Netherlands.
    Hamberg P; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam/Schiedam, the Netherlands.
    Herbschleb KH; Department of Internal Medicine, St. Antonius Ziekenhuis, Nieuwegein, The Netherlands.
    van der Hulle T; Department of Medical Oncology, LUMC, Leiden, the Netherlands.
    Lagerveld BW; Department of Urology, OLVG, Amsterdam, The Netherlands.
    van Oijen MG; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC location University of Amsterdam, 4F De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.
    Oosting SF; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
    van Thienen JV; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
    van der Veldt AA; Department of Medical Oncology, Department of Radiology & Nuclear Medicine, Erasmus Medical Center-Cancer Institute, Rotterdam, the Netherlands.
    Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands.
    Zeijdner EE; Dutch Oncology Research Platform, Utrecht, The Netherlands.
    Aben KK; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.; Department for Health Evidence, Radboud University Medical Centre, Nijmegen, The Netherlands.
    van den Hurk C; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
    Zondervan PJ; Department of Urology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.
    Bins AD; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC location University of Amsterdam, 4F De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.
    Pokaż więcej
    Źródło:
    BMC cancer [BMC Cancer] 2023 Jul 11; Vol. 23 (1), pp. 648. Date of Electronic Publication: 2023 Jul 11.
    Typ publikacji:
    Multicenter Study; Journal Article
    MeSH Terms:
    Carcinoma, Renal Cell*/epidemiology
    Carcinoma, Renal Cell*/therapy
    Kidney Neoplasms*/epidemiology
    Kidney Neoplasms*/therapy
    Humans ; Netherlands/epidemiology ; Prospective Studies ; Quality of Life
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Cross-Resistance between Platinum-Based Chemotherapy and PARP Inhibitors in Castration-Resistant Prostate Cancer.
    Autorzy:
    Slootbeek PHJ; Department of Medical Oncology, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, The Netherlands.
    Kloots ISH; Department of Medical Oncology, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, The Netherlands.
    van Oort IM; Department of Urology, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, The Netherlands.
    Kroeze LI; Department of Pathology, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, The Netherlands.
    Schalken JA; Department of Urology, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, The Netherlands.
    Bloemendal HJ; Department of Medical Oncology, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, The Netherlands.
    Mehra N; Department of Medical Oncology, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, The Netherlands.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2023 May 18; Vol. 15 (10). Date of Electronic Publication: 2023 May 18.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Cancer treatments touch a wide range of values that count for patients and other stakeholders: What are the implications for decision-making?
    Autorzy:
    Vrinzen CEJ; Scientific Institute for Quality of Healthcare (IQ Healthcare), Radboud Institute of Health Sciences (RIHS), Radboudumc, Nijmegen, The Netherlands.; Netherlands Comprehensive Cancer Center (IKNL), Utrecht, The Netherlands.
    Bloemendal HJ; Department of Oncology, Radboud Institute of Health Sciences (RIHS), Radboudumc, Nijmegen, The Netherlands.
    Stuart E; Scientific Institute for Quality of Healthcare (IQ Healthcare), Radboud Institute of Health Sciences (RIHS), Radboudumc, Nijmegen, The Netherlands.
    Makady A; Janssen-Cilag B.V., Pharmaceutical Companies of Johnson & Johnson, Breda, The Netherlands.
    van Agthoven M; Janssen-Cilag B.V., Pharmaceutical Companies of Johnson & Johnson, Breda, The Netherlands.
    Koster M; Janssen-Cilag B.V., Pharmaceutical Companies of Johnson & Johnson, Breda, The Netherlands.
    Merkx MAW; Scientific Institute for Quality of Healthcare (IQ Healthcare), Radboud Institute of Health Sciences (RIHS), Radboudumc, Nijmegen, The Netherlands.; Netherlands Comprehensive Cancer Center (IKNL), Utrecht, The Netherlands.
    Hermens RPMG; Scientific Institute for Quality of Healthcare (IQ Healthcare), Radboud Institute of Health Sciences (RIHS), Radboudumc, Nijmegen, The Netherlands.
    Jeurissen PPT; Scientific Institute for Quality of Healthcare (IQ Healthcare), Radboud Institute of Health Sciences (RIHS), Radboudumc, Nijmegen, The Netherlands.
    Pokaż więcej
    Źródło:
    Cancer medicine [Cancer Med] 2023 Mar; Vol. 12 (5), pp. 6105-6116. Date of Electronic Publication: 2022 Nov 14.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Touch*
    Neoplasms*/drug therapy
    Humans ; Decision Making ; Quality of Life ; Medical Oncology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Four-year effects of exercise on fatigue and physical activity in patients with cancer.
    Autorzy:
    Witlox L; Department of Clinical Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, PO Box 85500, STR 6.131, 3508 GA, Utrecht, The Netherlands.
    Hiensch AE; Department of Clinical Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, PO Box 85500, STR 6.131, 3508 GA, Utrecht, The Netherlands.
    Velthuis MJ; Netherlands Comprehensive Cancer Organisation (IKNL), PO Box 19079, 3501 DB, Utrecht, The Netherlands.
    Steins Bisschop CN; Department of Clinical Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, PO Box 85500, STR 6.131, 3508 GA, Utrecht, The Netherlands.
    Los M; Department of Medical Oncology, St. Antonius Ziekenhuis, Koekoekslaan 1, 3435 CM, Nieuwegein, The Netherlands.
    Erdkamp FLG; Department of Internal Medicine - Medical Oncology, Obis Medisch Centrum, Dr van der Hoffplein 1, 6166 BG, Sittard-Geleen, The Netherlands.
    Bloemendal HJ; Department of Internal Medicine, Meander Medical Center, Maatweg 3, 3818 TZ, Amersfoort, The Netherlands.
    Verhaar M; Department of Internal Medicine, Hofpoort Ziekenhuis, Polanerbaan 2, 3447 GN, Woerden, The Netherlands.
    Ten Bokkel Huinink D; Department of Internal Medicine, Diakonessenhuis, Bosboomstraat 1, 3582 KE, Utrecht, The Netherlands.
    van der Wall E; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
    Peeters PHM; Department of Clinical Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, PO Box 85500, STR 6.131, 3508 GA, Utrecht, The Netherlands.
    May AM; Department of Clinical Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, PO Box 85500, STR 6.131, 3508 GA, Utrecht, The Netherlands. .
    Pokaż więcej
    Źródło:
    BMC medicine [BMC Med] 2018 Jun 08; Vol. 16 (1), pp. 86. Date of Electronic Publication: 2018 Jun 08.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Exercise/*physiology
    Exercise Therapy/*methods
    Fatigue/*rehabilitation
    Neoplasms/*rehabilitation
    Quality of Life/*psychology
    Female ; Humans ; Male ; Middle Aged
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative.
    Autorzy:
    Coebergh van den Braak RRJ; a Department of Surgery , Erasmus MC University Medical Center , Rotterdam , The Netherlands.
    van Rijssen LB; b Department of Surgery , Academic Medical Center, Cancer Center Amsterdam , Amsterdam , The Netherlands.
    van Kleef JJ; c Department of Medical Oncology , Academic Medical Center , Amsterdam , The Netherlands.
    Vink GR; d Netherlands Comprehensive Cancer Organization , Utrecht , The Netherlands.; e Department of Medical Oncology , University Medical Center Utrecht , Utrecht , The Netherlands.
    Berbee M; f Department of Radiation Oncology , Maastro Clinic , Maastricht , The Netherlands.
    van Berge Henegouwen MI; b Department of Surgery , Academic Medical Center, Cancer Center Amsterdam , Amsterdam , The Netherlands.
    Bloemendal HJ; g Department of Medical Oncology , Meander Medisch Centrum , Amersfoort , The Netherlands.
    Bruno MJ; h Department of Gastroenterology and Hepatology , Erasmus MC University Medical Center , Rotterdam , The Netherlands.
    Burgmans MC; i Department of Radiology , Leiden University Medical Center , Leiden , The Netherlands.
    Busch ORC; b Department of Surgery , Academic Medical Center, Cancer Center Amsterdam , Amsterdam , The Netherlands.
    Coene PPLO; j Department of Surgery , Maasstad Hospital , Rotterdam , The Netherlands.
    Coupé VMH; k Department of Epidemiology and Biostatistics , VU University Medical Center , Amsterdam , The Netherlands.
    Dekker JWT; l Department of Surgery , Reinier de Graaf Hospital , Delft , The Netherlands.
    van Eijck CHJ; a Department of Surgery , Erasmus MC University Medical Center , Rotterdam , The Netherlands.
    Elferink MAG; d Netherlands Comprehensive Cancer Organization , Utrecht , The Netherlands.
    Erdkamp FLG; m Department of Medical Oncology , Zuyderland Medisch Centrum , Heerlen , The Netherlands.
    van Grevenstein WMU; n Department of Surgery , University Medical Center Utrecht , Utrecht , The Netherlands.
    de Groot JWB; o Department of Medical Oncology , Isala, Zwolle , The Netherlands.
    van Grieken NCT; p Department of Pathology , VU University Medical Center, Cancer Center Amsterdam , Amsterdam , The Netherlands.
    de Hingh IHJT; q Department of Surgery , Catharina Hospital , Eindhoven , The Netherlands.
    Hulshof MCCM; r Department of Radiotherapy , Academic Medical Center, Cancer Center Amsterdam , Amsterdam , The Netherlands.
    Ijzermans JNM; a Department of Surgery , Erasmus MC University Medical Center , Rotterdam , The Netherlands.
    Kwakkenbos L; s Living with Hope , Heemstede , The Netherlands.
    Lemmens VEPP; d Netherlands Comprehensive Cancer Organization , Utrecht , The Netherlands.
    Los M; t Department of Medical Oncology , St. Antonius Hospital , Nieuwegein , The Netherlands.
    Meijer GA; u Department of Pathology , Netherlands Cancer Institute , Amsterdam , The Netherlands.
    Molenaar IQ; n Department of Surgery , University Medical Center Utrecht , Utrecht , The Netherlands.
    Nieuwenhuijzen GAP; q Department of Surgery , Catharina Hospital , Eindhoven , The Netherlands.
    de Noo ME; v Department of Surgery , Deventer Hospital , Deventer , The Netherlands.
    van de Poll-Franse LV; w Research Department , Tilburg University , Tilburg , The Netherlands.
    Punt CJA; c Department of Medical Oncology , Academic Medical Center , Amsterdam , The Netherlands.
    Rietbroek RC; x Department of Medical Oncology , Rode Kruis Hospital , Beverwijk , The Netherlands.
    Roeloffzen WWH; y Department of Medical Oncology , Treant Zorggroep , Hoogeveen , The Netherlands.
    Rozema T; z Department of Radiotherapy , Instituut Verbeeten , Tilburg , The Netherlands.
    Ruurda JP; n Department of Surgery , University Medical Center Utrecht , Utrecht , The Netherlands.
    van Sandick JW; aa Department of Surgery , Netherlands Cancer Institute - Antoni van Leeuwenhoek , Amsterdam , The Netherlands.
    Schiphorst AHW; ab Department of Surgery , Diakonessenhuis , Utrecht , The Netherlands.
    Schipper H; ac Stichting voor Patiënten met Kanker aan het Spijsverteringskanaal (SPKS) , Utrecht , The Netherlands.
    Siersema PD; ad Department of Gastroenterology , Radboud University Medical Center , Nijmegen , The Netherlands.
    Slingerland M; ae Department of Medical Oncology , Leiden University Medical Center , Leiden , The Netherlands.
    Sommeijer DW; af Department of Medical Oncology , Flevoziekenhuis , Almere , The Netherlands.
    Spaander MCW; h Department of Gastroenterology and Hepatology , Erasmus MC University Medical Center , Rotterdam , The Netherlands.
    Sprangers MAG; ag Department of Medical Psychology , Academic Medical Center , Amsterdam , The Netherlands.
    Stockmann HBAC; ah Department of Surgery , Kennemer Gasthuis , Haarlem , The Netherlands.
    Strijker M; b Department of Surgery , Academic Medical Center, Cancer Center Amsterdam , Amsterdam , The Netherlands.
    van Tienhoven G; r Department of Radiotherapy , Academic Medical Center, Cancer Center Amsterdam , Amsterdam , The Netherlands.
    Timmermans LM; ac Stichting voor Patiënten met Kanker aan het Spijsverteringskanaal (SPKS) , Utrecht , The Netherlands.
    Tjin-A-Ton MLR; ai Department of Medical Oncology , Hospital Rivierenland , Tiel , The Netherlands.
    van der Velden AMT; aj Department of Medical Oncology , Tergooi Hospital , Hilversum , The Netherlands.
    Verhaar MJ; ak Department of Medical Oncology , Zuwe Hofpoort Hospital , Woerden , The Netherlands.
    Verkooijen HM; al Department of Epidemiology , University Medical Center Utrecht , Utrecht , The Netherlands.
    Vles WJ; am Department of Surgery , Ikazia Hospital , Rotterdam , The Netherlands.
    de Vos-Geelen JMPGM; an Department of Medical Oncology , Maastricht University Medical Center , Maastricht , The Netherlands.
    Wilmink JW; c Department of Medical Oncology , Academic Medical Center , Amsterdam , The Netherlands.
    Zimmerman DDE; ao Department of Surgery , Elisabeth-Tweesteden Hospital , Tilburg , The Netherlands.
    van Oijen MGH; c Department of Medical Oncology , Academic Medical Center , Amsterdam , The Netherlands.; d Netherlands Comprehensive Cancer Organization , Utrecht , The Netherlands.
    Koopman M; e Department of Medical Oncology , University Medical Center Utrecht , Utrecht , The Netherlands.
    Besselink MGH; b Department of Surgery , Academic Medical Center, Cancer Center Amsterdam , Amsterdam , The Netherlands.
    van Laarhoven HWM; c Department of Medical Oncology , Academic Medical Center , Amsterdam , The Netherlands.
    Pokaż więcej
    Corporate Authors:
    Dutch Pancreatic Cancer Group, Dutch Upper GI Cancer Group and PLCRC working group.
    Źródło:
    Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2018 Feb; Vol. 57 (2), pp. 195-202. Date of Electronic Publication: 2017 Jul 19.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Gastrointestinal Neoplasms*
    Research Design*
    Observational Studies as Topic/*methods
    Randomized Controlled Trials as Topic/*methods
    Biological Specimen Banks ; Cohort Studies ; Humans ; Registries
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    A randomised, phase II study of repeated rhenium-188-HEDP combined with docetaxel and prednisone versus docetaxel and prednisone alone in castration-resistant prostate cancer (CRPC) metastatic to bone; the Taxium II trial.
    Autorzy:
    van Dodewaard-de Jong JM; Department of Medical Oncology, VU University Medical Centre, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. .; Department of Medical Oncology, Meander Medical Centre, Maatweg 3, 3813 TZ, Amersfoort, The Netherlands. .
    de Klerk JMH; Department of Nuclear Medicine, Meander Medical Centre, Maatweg 3, 3813 TZ, Amersfoort, The Netherlands.
    Bloemendal HJ; Department of Medical Oncology, Meander Medical Centre, Maatweg 3, 3813 TZ, Amersfoort, The Netherlands.; Department of Medical Oncology, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
    Oprea-Lager DE; Department of Radiology & Nuclear Medicine, VU University Medical Centre, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
    Hoekstra OS; Department of Radiology & Nuclear Medicine, VU University Medical Centre, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
    van den Berg HP; Department of Medical Oncology, Tergooi Medical Hospital, Van Riebeeckweg 212, 1213 XZ, Hilversum, The Netherlands.
    Los M; Department of Medical Oncology, St Antonius Hospital Utrecht, Soestwetering 1, 3543 AZ, Utrecht, The Netherlands.
    Beeker A; Department of Medical Oncology, Spaarne Gasthuis, Spaarnepoort 1, 2134 TM, Hoofddorp, The Netherlands.
    Jonker MA; Department of Epidemiology and Biostatistics, VU University Medical Centre, De Boelelaan 1089a, 1081 HV, Amsterdam, The Netherlands.
    O'Sullivan JM; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Lisburn Road, Belfast, BT9 7AB, Northern Ireland, UK.
    Verheul HMW; Department of Medical Oncology, VU University Medical Centre, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
    van den Eertwegh AJM; Department of Medical Oncology, VU University Medical Centre, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
    Pokaż więcej
    Źródło:
    European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2017 Aug; Vol. 44 (8), pp. 1319-1327. Date of Electronic Publication: 2017 Apr 18.
    Typ publikacji:
    Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
    MeSH Terms:
    Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
    Bone Neoplasms/*secondary
    Etidronic Acid/*therapeutic use
    Organometallic Compounds/*therapeutic use
    Prednisone/*therapeutic use
    Prostatic Neoplasms, Castration-Resistant/*drug therapy
    Prostatic Neoplasms, Castration-Resistant/*pathology
    Taxoids/*therapeutic use
    Aged ; Aged, 80 and over ; Disease-Free Survival ; Docetaxel ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer: a proof-of-concept study in the preoperative window period (ImPACCT).
    Autorzy:
    Ubink I; Department of Surgical Oncology, Cancer Center, University Medical Center Utrecht, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands.
    Bloemendal HJ; Department of Medical Oncology, Cancer Center, University Medical Center Utrecht, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands.; Department of Medical Oncology, Meander Medical Center, Maatweg 3, 3813TZ, Amersfoort, the Netherlands.
    Elias SG; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Universiteitsweg 100, 3584CG, Utrecht, The Netherlands.
    Brink MA; Department of Gastroenterology, Meander Medical Center, Maatweg 3, 3813TZ, Amersfoort, the Netherlands.
    Schwartz MP; Department of Gastroenterology, Meander Medical Center, Maatweg 3, 3813TZ, Amersfoort, the Netherlands.
    Holierhoek YCW; Department of Gastroenterology, Meander Medical Center, Maatweg 3, 3813TZ, Amersfoort, the Netherlands.
    Verheijen PM; Department of Surgery, Meander Medical Center, Maatweg 3, 3813TZ, Amersfoort, the Netherlands.
    Boerman AW; Department of Medical Oncology, Meander Medical Center, Maatweg 3, 3813TZ, Amersfoort, the Netherlands.
    Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, 's-Gravendijkwal 230, 3015CE, Rotterdam, the Netherlands.
    de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands.
    de Weger RA; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands.
    van Grevenstein WMU; Department of Surgical Oncology, Cancer Center, University Medical Center Utrecht, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands.
    Koopman M; Department of Medical Oncology, Cancer Center, University Medical Center Utrecht, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands.
    Lolkema MP; Department of Medical Oncology, Erasmus MC Cancer Institute, 's-Gravendijkwal 230, 3015CE, Rotterdam, the Netherlands.
    Kranenburg O; Department of Surgical Oncology, Cancer Center, University Medical Center Utrecht, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands. .
    Borel Rinkes IHM; Department of Surgical Oncology, Cancer Center, University Medical Center Utrecht, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands. .
    Pokaż więcej
    Źródło:
    BMC cancer [BMC Cancer] 2017 Apr 19; Vol. 17 (1), pp. 282. Date of Electronic Publication: 2017 Apr 19.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Antineoplastic Agents/*therapeutic use
    Colorectal Neoplasms/*drug therapy
    Imatinib Mesylate/*therapeutic use
    Chemotherapy, Adjuvant ; Clinical Trials, Phase II as Topic ; Colorectal Neoplasms/pathology ; Humans ; Multicenter Studies as Topic ; Preoperative Period ; Prognosis ; Research Design ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Effects of an 18-week exercise programme started early during breast cancer treatment: a randomised controlled trial.
    Autorzy:
    Travier N; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, PO Box 85500, STR 6.131, 3508 GA, Utrecht, The Netherlands. .; Unit of Nutrition and Cancer, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, 08907, Spain. .; Department of Clinical Sciences, University of Barcelona, Barcelona, 08907, Spain. .
    Velthuis MJ; Comprehensive Cancer Organisation (IKNL), PO Box 19079, 3501 DB, Utrecht, The Netherlands. .
    Steins Bisschop CN; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, PO Box 85500, STR 6.131, 3508 GA, Utrecht, The Netherlands. .
    van den Buijs B; Department of Rehabilitation, Nursing Sciences and Sport, University Medical Center Utrecht, Heidelberglaan 100, 3584 CG, Utrecht, The Netherlands. .
    Monninkhof EM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, PO Box 85500, STR 6.131, 3508 GA, Utrecht, The Netherlands. .
    Backx F; Department of Rehabilitation, Nursing Sciences and Sport, University Medical Center Utrecht, Heidelberglaan 100, 3584 CG, Utrecht, The Netherlands. .
    Los M; Medical Oncology, St. Antonius Ziekenhuis, Koekoekslaan 1, 3435 CM, Nieuwegein, The Netherlands. .
    Erdkamp F; Internal Medicine - Medical Oncology, Obis Medisch Centrum, Dr vander Hoffplein 1, 6166 BG, Sittard-Geleen, The Netherlands. .
    Bloemendal HJ; Department of Internal Medicine, Medical Center, Maatweg 3, 3818 TZ, Amersfoort, The Netherlands. h.bloemendal@meandermc.nl.
    Rodenhuis C; Department of Radiation Oncology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CG, Utrecht, The Netherlands. .
    de Roos MA; Department of Surgery, Ziekenhuis Rivierenland, President Kennedylaan 1, 4002 WP, Tiel, The Netherlands. .
    Verhaar M; Department of internal medicine, Hofpoort Ziekenhuis, Polanerbaan 2, 3447 GN, Woerden, The Netherlands. .
    ten Bokkel Huinink D; Internal Medicine, Diakonessenhuis, Bosboomstraat 1, 3582 KE, Utrecht, The Netherlands. .
    van der Wall E; Cancer Center, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. .
    Peeters PH; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, PO Box 85500, STR 6.131, 3508 GA, Utrecht, The Netherlands. .
    May AM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, PO Box 85500, STR 6.131, 3508 GA, Utrecht, The Netherlands. .
    Pokaż więcej
    Źródło:
    BMC medicine [BMC Med] 2015 Jun 08; Vol. 13, pp. 121. Date of Electronic Publication: 2015 Jun 08.
    Typ publikacji:
    Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Breast Neoplasms/*psychology
    Breast Neoplasms/*rehabilitation
    Exercise Therapy/*methods
    Fatigue/*prevention & control
    Adult ; Aged ; Breast Neoplasms/drug therapy ; Depression/etiology ; Depression/prevention & control ; Female ; Humans ; Middle Aged ; Muscle Strength ; Physical Fitness ; Quality of Life
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    A phase I study of combined docetaxel and repeated high activity 186Re-HEDP in castration-resistant prostate cancer (CRPC) metastatic to bone (the TAXIUM trial).
    Autorzy:
    van Dodewaard-de Jong JM; Department of Internal Medicine, Meander Medical Centre, Postbox 1502, 3800 BM, Amersfoort, The Netherlands. />de Klerk JM
    Bloemendal HJ
    van Bezooijen BP
    de Haas MJ
    Wilson RH
    O'Sullivan JM
    Pokaż więcej
    Źródło:
    European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2011 Nov; Vol. 38 (11), pp. 1990-8. Date of Electronic Publication: 2011 Jul 27.
    Typ publikacji:
    Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Orchiectomy*
    Bone Neoplasms/*secondary
    Chemoradiotherapy/*adverse effects
    Chemoradiotherapy/*methods
    Etidronic Acid/*adverse effects
    Organometallic Compounds/*adverse effects
    Prostatic Neoplasms/*therapy
    Taxoids/*adverse effects
    Aged ; Docetaxel ; Etidronic Acid/therapeutic use ; Humans ; Male ; Middle Aged ; Organometallic Compounds/therapeutic use ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/surgery ; Radiotherapy Dosage ; Taxoids/therapeutic use ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-12 z 12

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies